Ozempic Craze: Is Weight Loss Worth the Risks? Concerns Rise Over Off-Label Use in Malaysia

2025-06-10
Ozempic Craze: Is Weight Loss Worth the Risks? Concerns Rise Over Off-Label Use in Malaysia
Malay Mail

Kuala Lumpur, June 11 — The global pursuit of weight loss solutions has led to a surge in interest surrounding Ozempic, a medication primarily prescribed for managing type 2 diabetes. However, a concerning trend has emerged: the off-label use of Ozempic for weight loss among individuals without diabetes. This practice has sparked warnings from health professionals and regulatory bodies, raising questions about its safety and efficacy.

What is Ozempic?

Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist. It works by mimicking the effects of a natural hormone that regulates blood sugar levels, slows down food digestion, and reduces appetite. It’s approved for use in adults with type 2 diabetes to improve blood sugar control, especially when combined with diet and exercise. The drug is administered as an injection once weekly.

The Weight Loss Phenomenon: Why Ozempic is Trending

Clinical trials have shown that Ozempic can lead to significant weight loss, prompting many non-diabetic individuals to seek it for cosmetic reasons. Social media platforms have amplified this trend, with influencers and celebrities sharing their experiences with the drug. The perceived rapid results have fueled demand, leading to shortages for patients who genuinely need it to manage their diabetes.

Concerns and Warnings: Risks of Off-Label Use

While Ozempic can be effective for weight loss, health experts caution against its off-label use. Here's why:

  • Safety Concerns: Ozempic is not approved for weight loss in individuals without diabetes. The long-term effects of using the drug for this purpose are not fully understood.
  • Side Effects: Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain. More serious side effects, although rare, can include pancreatitis, gallbladder problems, and kidney issues.
  • Ethical Considerations: Prioritizing weight loss over the needs of diabetic patients is ethically questionable, especially when the drug is in short supply.
  • Lack of Medical Supervision: Off-label use often occurs without proper medical supervision, increasing the risk of adverse effects and potential interactions with other medications.
  • Potential for Disordered Eating: Relying on medication for weight loss can reinforce unhealthy eating habits and potentially contribute to disordered eating patterns.

Regulatory Response and Recommendations

The Ministry of Health (MOH) in Malaysia has issued warnings about the inappropriate use of Ozempic. They emphasize that the drug should only be prescribed by registered medical practitioners and used for its approved indication – managing type 2 diabetes. The MOH is also monitoring the supply of Ozempic to ensure that diabetic patients have access to the medication.

Healthy Weight Loss: A Sustainable Approach

Experts recommend a holistic approach to weight loss that focuses on sustainable lifestyle changes. This includes:

  • Balanced Diet: Consuming a nutrient-rich diet with controlled portion sizes.
  • Regular Exercise: Engaging in at least 150 minutes of moderate-intensity aerobic exercise per week.
  • Behavioral Modifications: Addressing emotional eating and developing healthy coping mechanisms.
  • Professional Guidance: Consulting with a registered dietitian or healthcare professional for personalized advice.

Recommendations
Recommendations